Skip to main content
Clinical Trials/NL-OMON31829
NL-OMON31829
Completed
Not Applicable

The value of diffusion-weighted MR imaging and biomarkers in cerebrospinal fluid in acute spinal cord injury as predictors of outcome. - SPinal cord Diagnostic Improvements (SPIDI) study

niversitair Medisch Centrum Sint Radboud0 sites10 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
spinal cord injury
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
10
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • closed spinal cord injury
  • associated neurologic deficit
  • primarily referred to UMC St. Radboud
  • Glasgow Coma Scale of 15

Exclusion Criteria

  • penetrating spinal cord injury
  • normal neurologic examination
  • ischaemic spinal cord injury
  • traumatic brain injury
  • pre\-existent neurological disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials